Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
244,000
-5,500 (-2.20%)
Mar 11, 2025, 9:00 AM KST

Hanmi Pharm. Revenue

In the year 2024, Hanmi Pharm. had annual revenue of 1.50T KRW with 0.31% growth. Hanmi Pharm. had revenue of 351.61B in the quarter ending December 31, 2024, a decrease of -16.75%.

Revenue
1,495.50B
Revenue Growth
+0.31%
P/S Ratio
2.06
Revenue / Employee
641.85M
Employees
2,330
Market Cap
3,081.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,495.50B4.61B0.31%
Dec 31, 20231,490.89B159.34B11.97%
Dec 31, 20221,331.55B128.36B10.67%
Dec 31, 20211,203.19B127.33B11.84%
Dec 31, 20201,075.85B-37.80B-3.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,547.32B
Celltrion 2,876.25B
ALTEOGEN 74.38B
HLB Co., Ltd. 51.92B
Yuhan 2,008.84B
SK Biopharmaceuticals 511.33B
Sam Chun Dang Pharm. 208.22B
LigaChem Biosciences 101.42B
Revenue Rankings